<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Akebia Therapeutics, Inc. (AKBA) - Company Filings</title>
    <link>https://www.developersdigest.tech/markets/akba/filings</link>
    <description>Latest company filings for Akebia Therapeutics, Inc. (AKBA) - annual reports, quarterly reports, major events, and insider trades, newest first.</description>
    <language>en</language>
    <lastBuildDate>Mon, 13 Jul 2026 11:58:21 GMT</lastBuildDate>
    <atom:link href="https://www.developersdigest.tech/markets/akba/filings/feed.xml" rel="self" type="application/rss+xml" />
    <item>
      <title><![CDATA[AKBA: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000009375126000200/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000093751-26-000200</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-05-12.]]></description>
      <pubDate>Tue, 12 May 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702226000039/akba-20260331.htm</link>
      <guid isPermaLink="false">0001517022-26-000039</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Quarterly report (10-Q) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702226000038/akba-20260507.htm</link>
      <guid isPermaLink="false">0001517022-26-000038</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Major company event (8-K) on 2026-05-07.]]></description>
      <pubDate>Thu, 07 May 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Annual report to shareholders (ARS)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000114036126017532/ef20071767_ars.pdf</link>
      <guid isPermaLink="false">0001140361-26-017532</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Annual report to shareholders (ARS) on 2026-04-29.]]></description>
      <pubDate>Wed, 29 Apr 2026 12:00:00 GMT</pubDate>
      <category>ARS</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Proxy materials (DEFA14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702226000035/a2026defa14a.htm</link>
      <guid isPermaLink="false">0001517022-26-000035</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Proxy materials (DEFA14A) on 2026-04-28.]]></description>
      <pubDate>Tue, 28 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEFA14A</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Proxy statement (DEF 14A)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702226000034/akba-20260428.htm</link>
      <guid isPermaLink="false">0001517022-26-000034</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Proxy statement (DEF 14A) on 2026-04-28.]]></description>
      <pubDate>Tue, 28 Apr 2026 12:00:00 GMT</pubDate>
      <category>DEF 14A</category>
    </item>
    <item>
      <title><![CDATA[AKBA: PRE 14A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702226000029/akba-20260415.htm</link>
      <guid isPermaLink="false">0001517022-26-000029</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a PRE 14A (PRE 14A) on 2026-04-15.]]></description>
      <pubDate>Wed, 15 Apr 2026 12:00:00 GMT</pubDate>
      <category>PRE 14A</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000163504626000005/xslF345X06/primarydocument.xml</link>
      <guid isPermaLink="false">0001635046-26-000005</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider trade (4) on 2026-04-03.]]></description>
      <pubDate>Fri, 03 Apr 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKBA: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000163504626000004/xslF345X06/primarydocument.xml</link>
      <guid isPermaLink="false">0001635046-26-000004</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a New insider ownership (3) on 2026-04-03.]]></description>
      <pubDate>Fri, 03 Apr 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702226000024/akba-20260327.htm</link>
      <guid isPermaLink="false">0001517022-26-000024</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Major company event (8-K) on 2026-04-01.]]></description>
      <pubDate>Wed, 01 Apr 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AKBA: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000010290926000566/xslSCHEDULE_13G_X02/primary_doc.xml</link>
      <guid isPermaLink="false">0000102909-26-000566</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-03-26.]]></description>
      <pubDate>Thu, 26 Mar 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000159146726000003/xslF345X05/primarydocument.xml</link>
      <guid isPermaLink="false">0001591467-26-000003</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider trade (4) on 2026-03-05.]]></description>
      <pubDate>Thu, 05 Mar 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Annual report (10-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702226000020/akba-20251231.htm</link>
      <guid isPermaLink="false">0001517022-26-000020</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Annual report (10-K) on 2026-02-26.]]></description>
      <pubDate>Thu, 26 Feb 2026 12:00:00 GMT</pubDate>
      <category>10-K</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702226000019/akba-20260226.htm</link>
      <guid isPermaLink="false">0001517022-26-000019</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Major company event (8-K) on 2026-02-26.]]></description>
      <pubDate>Thu, 26 Feb 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AKBA: SCHEDULE 13G]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000009375126000019/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0000093751-26-000019</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a SCHEDULE 13G (SCHEDULE 13G) on 2026-02-09.]]></description>
      <pubDate>Mon, 09 Feb 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000210726426000006/xslF345X05/primarydocument.xml</link>
      <guid isPermaLink="false">0002107264-26-000006</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000200773026000002/xslF345X05/primarydocument.xml</link>
      <guid isPermaLink="false">0002007730-26-000002</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000176250726000002/xslF345X05/primarydocument.xml</link>
      <guid isPermaLink="false">0001762507-26-000002</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000166188726000002/xslF345X05/primarydocument.xml</link>
      <guid isPermaLink="false">0001661887-26-000002</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000161983426000002/xslF345X05/primarydocument.xml</link>
      <guid isPermaLink="false">0001619834-26-000002</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000159146726000002/xslF345X05/primarydocument.xml</link>
      <guid isPermaLink="false">0001591467-26-000002</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider trade (4) on 2026-02-04.]]></description>
      <pubDate>Wed, 04 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000210726426000005/xslF345X05/primarydocument.xml</link>
      <guid isPermaLink="false">0002107264-26-000005</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider trade (4) on 2026-02-03.]]></description>
      <pubDate>Tue, 03 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKBA: New insider ownership (3)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000210726426000004/xslF345X02/primarydocument.xml</link>
      <guid isPermaLink="false">0002107264-26-000004</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a New insider ownership (3) on 2026-02-03.]]></description>
      <pubDate>Tue, 03 Feb 2026 12:00:00 GMT</pubDate>
      <category>3</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000200773026000001/xslF345X05/primarydocument.xml</link>
      <guid isPermaLink="false">0002007730-26-000001</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider trade (4) on 2026-02-03.]]></description>
      <pubDate>Tue, 03 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000176250726000001/xslF345X05/primarydocument.xml</link>
      <guid isPermaLink="false">0001762507-26-000001</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider trade (4) on 2026-02-03.]]></description>
      <pubDate>Tue, 03 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000166188726000001/xslF345X05/primarydocument.xml</link>
      <guid isPermaLink="false">0001661887-26-000001</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider trade (4) on 2026-02-03.]]></description>
      <pubDate>Tue, 03 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000161983426000001/xslF345X05/primarydocument.xml</link>
      <guid isPermaLink="false">0001619834-26-000001</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider trade (4) on 2026-02-03.]]></description>
      <pubDate>Tue, 03 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000159146726000001/xslF345X05/primarydocument.xml</link>
      <guid isPermaLink="false">0001591467-26-000001</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider trade (4) on 2026-02-03.]]></description>
      <pubDate>Tue, 03 Feb 2026 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702226000013/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001517022-26-000013</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider sale notice (144) on 2026-02-02.]]></description>
      <pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702226000012/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001517022-26-000012</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider sale notice (144) on 2026-02-02.]]></description>
      <pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702226000011/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001517022-26-000011</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider sale notice (144) on 2026-02-02.]]></description>
      <pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702226000010/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001517022-26-000010</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider sale notice (144) on 2026-02-02.]]></description>
      <pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702226000009/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001517022-26-000009</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider sale notice (144) on 2026-02-02.]]></description>
      <pubDate>Mon, 02 Feb 2026 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702226000008/akba-20260127.htm</link>
      <guid isPermaLink="false">0001517022-26-000008</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Major company event (8-K) on 2026-01-30.]]></description>
      <pubDate>Fri, 30 Jan 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AKBA: SCHEDULE 13G/A]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000201238326000635/xslSCHEDULE_13G_X01/primary_doc.xml</link>
      <guid isPermaLink="false">0002012383-26-000635</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a SCHEDULE 13G/A (SCHEDULE 13G/A) on 2026-01-21.]]></description>
      <pubDate>Wed, 21 Jan 2026 12:00:00 GMT</pubDate>
      <category>SCHEDULE 13G/A</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702226000003/akba-20260112.htm</link>
      <guid isPermaLink="false">0001517022-26-000003</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Major company event (8-K) on 2026-01-12.]]></description>
      <pubDate>Mon, 12 Jan 2026 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702225000051/akba-20251128.htm</link>
      <guid isPermaLink="false">0001517022-25-000051</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Major company event (8-K) on 2025-12-01.]]></description>
      <pubDate>Mon, 01 Dec 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702225000048/akba-20251112.htm</link>
      <guid isPermaLink="false">0001517022-25-000048</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Major company event (8-K) on 2025-11-17.]]></description>
      <pubDate>Mon, 17 Nov 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702225000046/akba-20250930.htm</link>
      <guid isPermaLink="false">0001517022-25-000046</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Quarterly report (10-Q) on 2025-11-10.]]></description>
      <pubDate>Mon, 10 Nov 2025 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702225000045/akba-20251110.htm</link>
      <guid isPermaLink="false">0001517022-25-000045</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Major company event (8-K) on 2025-11-10.]]></description>
      <pubDate>Mon, 10 Nov 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702225000040/akba-20251028.htm</link>
      <guid isPermaLink="false">0001517022-25-000040</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Major company event (8-K) on 2025-10-28.]]></description>
      <pubDate>Tue, 28 Oct 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Quarterly report (10-Q)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000162828025038600/akba-20250630.htm</link>
      <guid isPermaLink="false">0001628280-25-038600</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Quarterly report (10-Q) on 2025-08-07.]]></description>
      <pubDate>Thu, 07 Aug 2025 12:00:00 GMT</pubDate>
      <category>10-Q</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702225000034/akba-20250807.htm</link>
      <guid isPermaLink="false">0001517022-25-000034</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Major company event (8-K) on 2025-08-07.]]></description>
      <pubDate>Thu, 07 Aug 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Employee stock plan (S-8)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000119312525175015/d912033ds8.htm</link>
      <guid isPermaLink="false">0001193125-25-175015</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Employee stock plan (S-8) on 2025-08-07.]]></description>
      <pubDate>Thu, 07 Aug 2025 12:00:00 GMT</pubDate>
      <category>S-8</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000156218025005201/xslF345X05/primarydocument.xml</link>
      <guid isPermaLink="false">0001562180-25-005201</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider trade (4) on 2025-07-01.]]></description>
      <pubDate>Tue, 01 Jul 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider sale notice (144)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702225000031/xsl144X01/primary_doc.xml</link>
      <guid isPermaLink="false">0001517022-25-000031</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider sale notice (144) on 2025-06-30.]]></description>
      <pubDate>Mon, 30 Jun 2025 12:00:00 GMT</pubDate>
      <category>144</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Major company event (8-K)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000151702225000030/akba-20250610.htm</link>
      <guid isPermaLink="false">0001517022-25-000030</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Major company event (8-K) on 2025-06-13.]]></description>
      <pubDate>Fri, 13 Jun 2025 12:00:00 GMT</pubDate>
      <category>8-K</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000156218025004724/xslF345X05/primarydocument.xml</link>
      <guid isPermaLink="false">0001562180-25-004724</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider trade (4) on 2025-06-11.]]></description>
      <pubDate>Wed, 11 Jun 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000156218025004723/xslF345X05/primarydocument.xml</link>
      <guid isPermaLink="false">0001562180-25-004723</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider trade (4) on 2025-06-11.]]></description>
      <pubDate>Wed, 11 Jun 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
    <item>
      <title><![CDATA[AKBA: Insider trade (4)]]></title>
      <link>https://www.sec.gov/Archives/edgar/data/1517022/000156218025004722/xslF345X05/primarydocument.xml</link>
      <guid isPermaLink="false">0001562180-25-004722</guid>
      <description><![CDATA[Akebia Therapeutics, Inc. filed a Insider trade (4) on 2025-06-11.]]></description>
      <pubDate>Wed, 11 Jun 2025 12:00:00 GMT</pubDate>
      <category>4</category>
    </item>
  </channel>
</rss>